Ownership history in Empirical Finance, LLC · 3 quarters on record
This page tracks every 13F SEC filing in which Empirical Finance, LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 800,000 | — | 0% | 0.00% | $21K | — |
| 2025 Q3 | UNCHANGED | 800,000 | — | 0% | 0.00% | $104K | — |
| 2025 Q2 | INITIATED | 800,000 | — | — | 0.01% | $192K | — |
As of 2025 Q4 — sorted by position size